CASATO, Milvia
 Distribuzione geografica
Continente #
NA - Nord America 322
EU - Europa 173
AS - Asia 28
OC - Oceania 8
SA - Sud America 6
AF - Africa 4
Totale 541
Nazione #
US - Stati Uniti d'America 313
IT - Italia 76
FR - Francia 40
DE - Germania 13
JP - Giappone 12
NL - Olanda 10
CA - Canada 8
AU - Australia 6
CN - Cina 6
GB - Regno Unito 6
ES - Italia 5
SE - Svezia 5
AL - Albania 4
UA - Ucraina 4
AE - Emirati Arabi Uniti 3
CZ - Repubblica Ceca 3
TH - Thailandia 3
ZA - Sudafrica 3
AT - Austria 2
CL - Cile 2
CO - Colombia 2
HK - Hong Kong 2
NZ - Nuova Zelanda 2
BE - Belgio 1
BG - Bulgaria 1
BR - Brasile 1
CD - Congo 1
EC - Ecuador 1
FI - Finlandia 1
GR - Grecia 1
IE - Irlanda 1
MX - Messico 1
PK - Pakistan 1
PS - Palestinian Territory 1
Totale 541
Città #
Rome 47
Ashburn 29
Buffalo 29
Fairfield 28
Woodbridge 28
Seattle 25
Santa Cruz 20
Houston 19
Cambridge 11
Chicago 8
Paris 7
Wilmington 6
Amsterdam 4
Ann Arbor 4
Boardman 4
Córdoba 4
Des Moines 4
Edmonton 4
Elbasan 4
Ajirokita 3
Bang Khae 3
Guangzhou 3
Los Angeles 3
Melbourne 3
Muizenberg 3
New York 3
Phoenix 3
Sunnyvale 3
Sydney 3
Akama 2
Crispano 2
Dallas 2
Falkenstein 2
Lake Forest 2
Latina 2
Medellín 2
New Brunswick 2
Oanakita 2
Rosny-sous-Bois 2
Stockholm 2
Vienna 2
Albany 1
Andover 1
Athens 1
Avigliano 1
Bari 1
Beijing 1
Bellingham 1
Bologna 1
Brentwood 1
Cardiff 1
Columbus 1
Concord 1
Council Bluffs 1
Crugers 1
Dartford 1
Easton 1
Edison 1
Fiuggi 1
Frankfurt am Main 1
Galway 1
Ghent 1
Groningen 1
Hamanocho 1
Hamilton 1
Hangzhou 1
Harigaya 1
Harper Woods 1
Helsinki 1
Islamabad 1
Jenin 1
Koriyama 1
Kowloon 1
Lainate 1
Las Vegas 1
Laurel 1
Leawood 1
Maarssen 1
Meda 1
Milan 1
Milpitas 1
Montesilvano Marina 1
Monza 1
Mountain View 1
Newham 1
Nuremberg 1
Oak Lawn 1
Ottawa 1
Pittsburgh 1
Portland 1
Prince George 1
Providence 1
Quito 1
Reutlingen 1
San Francisco 1
San Jose 1
Sete Lagoas 1
Sofia 1
Southend 1
Stillwater 1
Totale 398
Nome #
HBV messing with the B-cell genome leads to DLBCL, file e383531d-3460-15e8-e053-a505fe0a3de9 122
Reversion of anergy signatures in clonal CD21low B cells of mixed cryoglobulinemia after clearance of HCV viremia., file e383531e-5f0d-15e8-e053-a505fe0a3de9 122
International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement, file e383531a-d1ab-15e8-e053-a505fe0a3de9 64
Opposite Effects of mRNA-Based and Adenovirus-Vectored SARS-CoV-2 Vaccines on Regulatory T Cells: A Pilot Study, file ee26170f-6776-4109-b1c1-919aaf906df8 34
High prevalence of gluten sensitivity in a cohort of patients with undifferentiated connective tissue disease., file e3835326-befa-15e8-e053-a505fe0a3de9 31
Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2, file e383532d-d097-15e8-e053-a505fe0a3de9 23
Persistence of pathogenic B cell clones and relapse of cryoglobulinemic vasculitis in HCV-cured patients, file e383531d-344b-15e8-e053-a505fe0a3de9 20
CD21 low B cells are predictive markers of new digital ulcers in systemic sclerosis, file e383532c-6b7f-15e8-e053-a505fe0a3de9 20
Management of nonviral mixed cryoglobulinemia vasculitis refractory to rituximab: Data from a European collaborative study and review of the literature, file e383532e-b2ad-15e8-e053-a505fe0a3de9 17
Safety and effectiveness of biosimilar of Rituximab CT‐P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar), file e3835328-c76b-15e8-e053-a505fe0a3de9 16
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression, file e383532c-9695-15e8-e053-a505fe0a3de9 11
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis, file 11373644-fd21-42f3-8782-b1c1f18a09e4 9
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC), file 53fa576d-2e6a-4f4f-a159-340703d3831f 7
Dual stimulation by autoantigen and CpG fosters the proliferation of exhausted rheumatoid factor-specific CD21low B cells in hepatitis C virus-cured mixed cryoglobulinemia, file 5e7a7596-1048-4847-a5ca-fdf8c64bc276 7
The case for cost-effectively treating cryoglobulinemic vasculitis with interferon-free anti-hepatitis C virus therapy., file e3835314-1bec-15e8-e053-a505fe0a3de9 6
Relapse of HCV-Cryoglobulinemic Vasculitis Following Sustained Viral Response after Interferon-free Direct-Acting Antivirals, file e383532e-a7a1-15e8-e053-a505fe0a3de9 6
Interferon for hepatitis C virus-negative type II mixed cryoglobulinemia, file e3835311-9ee1-15e8-e053-a505fe0a3de9 4
Occult hepatitis C virus infection in type II mixed cryoglobulinaemia, file e3835312-4fa8-15e8-e053-a505fe0a3de9 4
Late relapses of hepatitis C virus-cured mixed cryoglobulinaemia associated with infection or cancer, file e383531b-29f0-15e8-e053-a505fe0a3de9 4
Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders, file e383532c-8ed7-15e8-e053-a505fe0a3de9 4
Provisional recommendations for SARS-CoV-2 vaccination in patients with cryoglobulinaemic vasculitis, file e383532e-7903-15e8-e053-a505fe0a3de9 4
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups, file e383532e-97ba-15e8-e053-a505fe0a3de9 4
Correction to: management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC), file 7542f1c7-caa3-4b41-82ec-4cbc1c084d3f 3
Efficacy and safety of long-term treatment with low-dose rituximab for relapsing mixed cryoglobulinemia vasculitis, file e3835326-b805-15e8-e053-a505fe0a3de9 3
Efficacy of low-dose rituximab for the treatment of mixed cryoglobulinemia vasculitis: Phase II clinical trial and systematic review, file e3835314-2e01-15e8-e053-a505fe0a3de9 2
Persistent Hepatitis C Virus-Associated Cryoglobulinemic Vasculitis Following Virus Eradication After Direct-Acting Antiviral Therapy Reply, file e383531f-6efa-15e8-e053-a505fe0a3de9 2
Long-lasting persistence of large B-cell clones in hepatitis C virus-cured patients with complete response of mixed cryoglobulinaemia vasculitis., file e3835320-3424-15e8-e053-a505fe0a3de9 2
International diagnostic guidelines for patients with HCV-related extrahepatic manifestations. A multidisciplinary expert statement, file e3835326-702d-15e8-e053-a505fe0a3de9 2
Clinical, neurophysiological, and skin biopsy findings in peripheral neuropathy associated with hepatitis C virus-related cryoglobulinemia, file e3835313-1000-15e8-e053-a505fe0a3de9 1
Clonal expansion and functional exhaustion of monoclonal marginal zone B cells in mixed cryoglobulinemia: The yin and yang of HCV-driven lymphoproliferation and autoimmunity, file e3835314-1889-15e8-e053-a505fe0a3de9 1
A phase II, single-arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection, file e3835314-2469-15e8-e053-a505fe0a3de9 1
Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection, file e383531a-8694-15e8-e053-a505fe0a3de9 1
DEC1/STRA13 is a key negative regulator of activation-induced proliferation of human B cells highly expressed in anergic cells, file e383531b-1482-15e8-e053-a505fe0a3de9 1
From the pathogenesis to the cure of indolent B-cell lymphoproliferative disorders associated with hepatitis C virus infection: which role for direct-acting antivirals?, file e383531f-4962-15e8-e053-a505fe0a3de9 1
Hepatitis B virus causes mixed cryoglobulinaemia by driving clonal expansion of innate B-cells producing a VH1-69-encoded antibody, file e383531f-6971-15e8-e053-a505fe0a3de9 1
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia, file e3835324-79a4-15e8-e053-a505fe0a3de9 1
A stereotyped light chain may shape virus-specific B-cell receptors in HCV-dependent lymphoproliferative disorders, file e3835325-857a-15e8-e053-a505fe0a3de9 1
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection, file e3835326-98e8-15e8-e053-a505fe0a3de9 1
Rheumatoid factor-producing CD21low anergic clonal B-cells in essential mixed cryoglobulinaemia: a model for autoantigen-driven pathogenesis of infectious and non-infectious cryoglobulinaemias, file e3835326-b542-15e8-e053-a505fe0a3de9 1
Clinico-immunologic outcomes of HCV-cured cryoglobulinemia: lower relapse rate with interferon-based than interferon-free therapy, file e3835328-5471-15e8-e053-a505fe0a3de9 1
Totale 565
Categoria #
all - tutte 1.376
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.376


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201949 0 0 0 0 0 0 0 0 0 13 19 17
2019/202061 7 4 2 4 9 3 4 6 7 6 3 6
2020/202172 2 5 2 2 2 7 4 11 7 18 9 3
2021/202282 2 8 3 4 6 5 5 9 6 3 23 8
2022/2023168 6 7 25 28 26 23 18 8 4 8 9 6
2023/2024104 1 8 8 8 20 26 12 11 5 5 0 0
Totale 565